DNA double-strand break repair capacity and risk of breast cancer

Carcinogenesis

Volumn 28, Issue 8, 2007, Pages 1726-1730

  Bau, Da Tian ^a,b   Mau, Yi Chien ^a   Ding, Shian Ling ^a,c   Wu, Pei Ei ^a   Shen, Chen Yang ^a,d,e  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Kang Ning Junior College of Medical Care and Management   (Taiwan)

^d ACADEMIA SINICA   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; EPSTEIN BARR VIRUS; FEMALE; GENE DOSAGE; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TRANSFORMED; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RANDOM ALLOCATION; RISK FACTORS;

EID: 34548084240     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm109     Document Type: Article

References (22)

1. Vogelstein,B. et al. (2002) New York: McGraw-Hill.
2. Venkitaraman,A.R. (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 108, 171-182.
3. Shen,C.Y. et al. (2000) Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis. Cancer Res., 60, 3884-3892.
4. Karran,P. (2000) DNA double strand break repair in mammalian cells. Curr. Opin. Genet. Dev., 10, 144-150.
5. Khanna,K.K. et al. (2001) DNA double-strand breaks: Signaling, repair and the cancer connection. Nat. Genet., 27, 247-254.
6. van Gent,D.C. et al. (2001) Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet., 2, 196-206.
7. Fu,YP. et al. (2003) Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: A multigenic study on cancer susceptibility. Cancer Res., 63, 2440-2446.
8. Cheng,T.C. et al. (2005) Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: A multigenic study on cancer susceptibility. Int. J. Cancer, 113 345-353.
9. Lo,Y.L. et al. (2005) Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK. Int. J. Cancer, 115, 276-283.
10. Beck,J.C. et al. (2001) Successful transformation of cryopreserved lymphocytes: A resource for epidemiological studies. Cancer Epidemiol. Biomarkers Prev., 10, 551-554.
11. Bau,D.T. et al. (2004) Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res., 64, 5013-5019.
12. Wang,H.C. et al. (2006) Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. Cancer Res., 66, 1391-1400.
13. Yang,P.S. et al. (1997) A case-control study of breast cancer in Taiwan - a low-incidence area. Br. J. Cancer, 75, 752-756.
14. Huang,C.S. et al. (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility. Cancer Res. 59, 4870-4875.
15. Bau,D.T. et al. (2006) The role of BRCA1 in non-homologous end-joining. Cancer Lett., 240, 1-8.
16. Zhong,Q. et al. (2002) BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks. J. Mol. Chem., 277, 28641-28647.
17. Coupier,I. et al. (2004) Fidelity of DNA double-strand break repair in heterozygous cell lines harbouring BRCA1 missense mutations. Oncogene, 23, 914-919.
18. Wei,Q. et al. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study. J. Natl. Cancer Inst., 92, 1764-1772.
19. Wei,Q. et al. (2003) Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J. Natl Cancer Inst., 95 308-315.
20. Moshous,D. et al. (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell, 105, 177-186.
21. Ahnesorg,P. et al. (2006) XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell, 124 301-313.
22. Buck,D. et al. (2006) Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124, 287-299.